ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 503B Compounding Pharmacies Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6O12760
Home | Market Reports | Health| Pharmacy
Global 503B Compounding Pharmacies Market Research Report 2022
BUY CHAPTERS

Global 503B Compounding Pharmacies Market Research Report 2025

Code: QYRE-Auto-6O12760
Report
March 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Nephron Pharmaceuticals Corporation
Olympia Pharmacy
Athenex Inc
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Empower Pharmacy
Central Admixture Pharmacy Services
QuVa Pharma
ASP Cares
Fagron Compounding Pharmacies
Carie Boyd’S Prescription Shop
Edge Pharma, Imprimis NJOF
IntegraDose Compounding services
Wells Pharma of Houston, LLC
US Compounding Inc.
SCA Pharma

503B Compounding Pharmacies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

503B Compounding Pharmacies Market

503B Compounding Pharmacies Market

The global market for 503B Compounding Pharmacies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for 503B Compounding Pharmacies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 503B Compounding Pharmacies.
The 503B Compounding Pharmacies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 503B Compounding Pharmacies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 503B Compounding Pharmacies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of 503B Compounding Pharmacies Market Report

Report Metric Details
Report Name 503B Compounding Pharmacies Market
CAGR 5%
Segment by Type
Segment by Application
  • On-line
  • Offline
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, Carie Boyd’S Prescription Shop, Edge Pharma, Imprimis NJOF, IntegraDose Compounding services, Wells Pharma of Houston, LLC, US Compounding Inc., SCA Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of 503B Compounding Pharmacies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the 503B Compounding Pharmacies Market report?

Ans: The main players in the 503B Compounding Pharmacies Market are Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, Carie Boyd’S Prescription Shop, Edge Pharma, Imprimis NJOF, IntegraDose Compounding services, Wells Pharma of Houston, LLC, US Compounding Inc., SCA Pharma

What are the Application segmentation covered in the 503B Compounding Pharmacies Market report?

Ans: The Applications covered in the 503B Compounding Pharmacies Market report are On-line, Offline

What are the Type segmentation covered in the 503B Compounding Pharmacies Market report?

Ans: The Types covered in the 503B Compounding Pharmacies Market report are Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/ Bupivacaine, Morphine, Other

Recommended Reports

Pharmacy Automation

Pharmaceutical Distribution

Specialty Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global 503B Compounding Pharmacies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Acetaminophen
1.2.3 Phenylephrine
1.2.4 Midazolam
1.2.5 Esmolol
1.2.6 Vancomycin
1.2.7 Epinephrine
1.2.8 Adenocaine
1.2.9 Fentanyl/ Bupivacaine
1.2.10 Morphine
1.3 Market by Application
1.3.1 Global 503B Compounding Pharmacies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 On-line
1.3.3 Offline
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global 503B Compounding Pharmacies Market Perspective (2020-2031)
2.2 Global 503B Compounding Pharmacies Growth Trends by Region
2.2.1 Global 503B Compounding Pharmacies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 503B Compounding Pharmacies Historic Market Size by Region (2020-2025)
2.2.3 503B Compounding Pharmacies Forecasted Market Size by Region (2026-2031)
2.3 503B Compounding Pharmacies Market Dynamics
2.3.1 503B Compounding Pharmacies Industry Trends
2.3.2 503B Compounding Pharmacies Market Drivers
2.3.3 503B Compounding Pharmacies Market Challenges
2.3.4 503B Compounding Pharmacies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top 503B Compounding Pharmacies Players by Revenue
3.1.1 Global Top 503B Compounding Pharmacies Players by Revenue (2020-2025)
3.1.2 Global 503B Compounding Pharmacies Revenue Market Share by Players (2020-2025)
3.2 Global 503B Compounding Pharmacies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by 503B Compounding Pharmacies Revenue
3.4 Global 503B Compounding Pharmacies Market Concentration Ratio
3.4.1 Global 503B Compounding Pharmacies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by 503B Compounding Pharmacies Revenue in 2024
3.5 Global Key Players of 503B Compounding Pharmacies Head office and Area Served
3.6 Global Key Players of 503B Compounding Pharmacies, Product and Application
3.7 Global Key Players of 503B Compounding Pharmacies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 503B Compounding Pharmacies Breakdown Data by Type
4.1 Global 503B Compounding Pharmacies Historic Market Size by Type (2020-2025)
4.2 Global 503B Compounding Pharmacies Forecasted Market Size by Type (2026-2031)
5 503B Compounding Pharmacies Breakdown Data by Application
5.1 Global 503B Compounding Pharmacies Historic Market Size by Application (2020-2025)
5.2 Global 503B Compounding Pharmacies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America 503B Compounding Pharmacies Market Size (2020-2031)
6.2 North America 503B Compounding Pharmacies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America 503B Compounding Pharmacies Market Size by Country (2020-2025)
6.4 North America 503B Compounding Pharmacies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe 503B Compounding Pharmacies Market Size (2020-2031)
7.2 Europe 503B Compounding Pharmacies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe 503B Compounding Pharmacies Market Size by Country (2020-2025)
7.4 Europe 503B Compounding Pharmacies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific 503B Compounding Pharmacies Market Size (2020-2031)
8.2 Asia-Pacific 503B Compounding Pharmacies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific 503B Compounding Pharmacies Market Size by Region (2020-2025)
8.4 Asia-Pacific 503B Compounding Pharmacies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America 503B Compounding Pharmacies Market Size (2020-2031)
9.2 Latin America 503B Compounding Pharmacies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America 503B Compounding Pharmacies Market Size by Country (2020-2025)
9.4 Latin America 503B Compounding Pharmacies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa 503B Compounding Pharmacies Market Size (2020-2031)
10.2 Middle East & Africa 503B Compounding Pharmacies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa 503B Compounding Pharmacies Market Size by Country (2020-2025)
10.4 Middle East & Africa 503B Compounding Pharmacies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Central Admixture Pharmacy Services
11.1.1 Central Admixture Pharmacy Services Company Details
11.1.2 Central Admixture Pharmacy Services Business Overview
11.1.3 Central Admixture Pharmacy Services 503B Compounding Pharmacies Introduction
11.1.4 Central Admixture Pharmacy Services Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.1.5 Central Admixture Pharmacy Services Recent Development
11.2 Nephron Pharmaceuticals Corporation
11.2.1 Nephron Pharmaceuticals Corporation Company Details
11.2.2 Nephron Pharmaceuticals Corporation Business Overview
11.2.3 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Introduction
11.2.4 Nephron Pharmaceuticals Corporation Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.2.5 Nephron Pharmaceuticals Corporation Recent Development
11.3 QuVa Pharma
11.3.1 QuVa Pharma Company Details
11.3.2 QuVa Pharma Business Overview
11.3.3 QuVa Pharma 503B Compounding Pharmacies Introduction
11.3.4 QuVa Pharma Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.3.5 QuVa Pharma Recent Development
11.4 Olympia Pharmacy
11.4.1 Olympia Pharmacy Company Details
11.4.2 Olympia Pharmacy Business Overview
11.4.3 Olympia Pharmacy 503B Compounding Pharmacies Introduction
11.4.4 Olympia Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.4.5 Olympia Pharmacy Recent Development
11.5 ASP Cares
11.5.1 ASP Cares Company Details
11.5.2 ASP Cares Business Overview
11.5.3 ASP Cares 503B Compounding Pharmacies Introduction
11.5.4 ASP Cares Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.5.5 ASP Cares Recent Development
11.6 Fagron Compounding Pharmacies
11.6.1 Fagron Compounding Pharmacies Company Details
11.6.2 Fagron Compounding Pharmacies Business Overview
11.6.3 Fagron Compounding Pharmacies 503B Compounding Pharmacies Introduction
11.6.4 Fagron Compounding Pharmacies Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.6.5 Fagron Compounding Pharmacies Recent Development
11.7 Athenex, Inc.
11.7.1 Athenex, Inc. Company Details
11.7.2 Athenex, Inc. Business Overview
11.7.3 Athenex, Inc. 503B Compounding Pharmacies Introduction
11.7.4 Athenex, Inc. Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.7.5 Athenex, Inc. Recent Development
11.8 Avella Specialty Pharmacy
11.8.1 Avella Specialty Pharmacy Company Details
11.8.2 Avella Specialty Pharmacy Business Overview
11.8.3 Avella Specialty Pharmacy 503B Compounding Pharmacies Introduction
11.8.4 Avella Specialty Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.8.5 Avella Specialty Pharmacy Recent Development
11.9 Atlas Pharmaceuticals
11.9.1 Atlas Pharmaceuticals Company Details
11.9.2 Atlas Pharmaceuticals Business Overview
11.9.3 Atlas Pharmaceuticals 503B Compounding Pharmacies Introduction
11.9.4 Atlas Pharmaceuticals Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.9.5 Atlas Pharmaceuticals Recent Development
11.10 Empower Pharmacy
11.10.1 Empower Pharmacy Company Details
11.10.2 Empower Pharmacy Business Overview
11.10.3 Empower Pharmacy 503B Compounding Pharmacies Introduction
11.10.4 Empower Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.10.5 Empower Pharmacy Recent Development
11.11 Carie Boyd’S Prescription Shop
11.11.1 Carie Boyd’S Prescription Shop Company Details
11.11.2 Carie Boyd’S Prescription Shop Business Overview
11.11.3 Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Introduction
11.11.4 Carie Boyd’S Prescription Shop Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.11.5 Carie Boyd’S Prescription Shop Recent Development
11.12 Edge Pharma, Imprimis NJOF
11.12.1 Edge Pharma, Imprimis NJOF Company Details
11.12.2 Edge Pharma, Imprimis NJOF Business Overview
11.12.3 Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Introduction
11.12.4 Edge Pharma, Imprimis NJOF Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.12.5 Edge Pharma, Imprimis NJOF Recent Development
11.13 IntegraDose Compounding services
11.13.1 IntegraDose Compounding services Company Details
11.13.2 IntegraDose Compounding services Business Overview
11.13.3 IntegraDose Compounding services 503B Compounding Pharmacies Introduction
11.13.4 IntegraDose Compounding services Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.13.5 IntegraDose Compounding services Recent Development
11.14 Wells Pharma of Houston, LLC
11.14.1 Wells Pharma of Houston, LLC Company Details
11.14.2 Wells Pharma of Houston, LLC Business Overview
11.14.3 Wells Pharma of Houston, LLC 503B Compounding Pharmacies Introduction
11.14.4 Wells Pharma of Houston, LLC Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.14.5 Wells Pharma of Houston, LLC Recent Development
11.15 US Compounding Inc.
11.15.1 US Compounding Inc. Company Details
11.15.2 US Compounding Inc. Business Overview
11.15.3 US Compounding Inc. 503B Compounding Pharmacies Introduction
11.15.4 US Compounding Inc. Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.15.5 US Compounding Inc. Recent Development
11.16 SCA Pharma
11.16.1 SCA Pharma Company Details
11.16.2 SCA Pharma Business Overview
11.16.3 SCA Pharma 503B Compounding Pharmacies Introduction
11.16.4 SCA Pharma Revenue in 503B Compounding Pharmacies Business (2020-2025)
11.16.5 SCA Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Nephron Pharmaceuticals Corporation
Olympia Pharmacy
Athenex Inc
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Empower Pharmacy
Central Admixture Pharmacy Services
QuVa Pharma
ASP Cares
Fagron Compounding Pharmacies
Carie Boyd’S Prescription Shop
Edge Pharma, Imprimis NJOF
IntegraDose Compounding services
Wells Pharma of Houston, LLC
US Compounding Inc.
SCA Pharma
List of Tables
 Table 1. Global 503B Compounding Pharmacies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Acetaminophen
 Table 3. Key Players of Phenylephrine
 Table 4. Key Players of Midazolam
 Table 5. Key Players of Esmolol
 Table 6. Key Players of Vancomycin
 Table 7. Key Players of Epinephrine
 Table 8. Key Players of Adenocaine
 Table 9. Global 503B Compounding Pharmacies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global 503B Compounding Pharmacies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global 503B Compounding Pharmacies Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global 503B Compounding Pharmacies Market Share by Region (2020-2025)
 Table 13. Global 503B Compounding Pharmacies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global 503B Compounding Pharmacies Market Share by Region (2026-2031)
 Table 15. 503B Compounding Pharmacies Market Trends
 Table 16. 503B Compounding Pharmacies Market Drivers
 Table 17. 503B Compounding Pharmacies Market Challenges
 Table 18. 503B Compounding Pharmacies Market Restraints
 Table 19. Global 503B Compounding Pharmacies Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global 503B Compounding Pharmacies Market Share by Players (2020-2025)
 Table 21. Global Top 503B Compounding Pharmacies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 503B Compounding Pharmacies as of 2024)
 Table 22. Ranking of Global Top 503B Compounding Pharmacies Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by 503B Compounding Pharmacies Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of 503B Compounding Pharmacies, Headquarters and Area Served
 Table 25. Global Key Players of 503B Compounding Pharmacies, Product and Application
 Table 26. Global Key Players of 503B Compounding Pharmacies, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global 503B Compounding Pharmacies Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global 503B Compounding Pharmacies Revenue Market Share by Type (2020-2025)
 Table 30. Global 503B Compounding Pharmacies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global 503B Compounding Pharmacies Revenue Market Share by Type (2026-2031)
 Table 32. Global 503B Compounding Pharmacies Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global 503B Compounding Pharmacies Revenue Market Share by Application (2020-2025)
 Table 34. Global 503B Compounding Pharmacies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global 503B Compounding Pharmacies Revenue Market Share by Application (2026-2031)
 Table 36. North America 503B Compounding Pharmacies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America 503B Compounding Pharmacies Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America 503B Compounding Pharmacies Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe 503B Compounding Pharmacies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe 503B Compounding Pharmacies Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe 503B Compounding Pharmacies Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific 503B Compounding Pharmacies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific 503B Compounding Pharmacies Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific 503B Compounding Pharmacies Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America 503B Compounding Pharmacies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America 503B Compounding Pharmacies Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America 503B Compounding Pharmacies Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa 503B Compounding Pharmacies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa 503B Compounding Pharmacies Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa 503B Compounding Pharmacies Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Central Admixture Pharmacy Services Company Details
 Table 52. Central Admixture Pharmacy Services Business Overview
 Table 53. Central Admixture Pharmacy Services 503B Compounding Pharmacies Product
 Table 54. Central Admixture Pharmacy Services Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 55. Central Admixture Pharmacy Services Recent Development
 Table 56. Nephron Pharmaceuticals Corporation Company Details
 Table 57. Nephron Pharmaceuticals Corporation Business Overview
 Table 58. Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product
 Table 59. Nephron Pharmaceuticals Corporation Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 60. Nephron Pharmaceuticals Corporation Recent Development
 Table 61. QuVa Pharma Company Details
 Table 62. QuVa Pharma Business Overview
 Table 63. QuVa Pharma 503B Compounding Pharmacies Product
 Table 64. QuVa Pharma Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 65. QuVa Pharma Recent Development
 Table 66. Olympia Pharmacy Company Details
 Table 67. Olympia Pharmacy Business Overview
 Table 68. Olympia Pharmacy 503B Compounding Pharmacies Product
 Table 69. Olympia Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 70. Olympia Pharmacy Recent Development
 Table 71. ASP Cares Company Details
 Table 72. ASP Cares Business Overview
 Table 73. ASP Cares 503B Compounding Pharmacies Product
 Table 74. ASP Cares Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 75. ASP Cares Recent Development
 Table 76. Fagron Compounding Pharmacies Company Details
 Table 77. Fagron Compounding Pharmacies Business Overview
 Table 78. Fagron Compounding Pharmacies 503B Compounding Pharmacies Product
 Table 79. Fagron Compounding Pharmacies Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 80. Fagron Compounding Pharmacies Recent Development
 Table 81. Athenex, Inc. Company Details
 Table 82. Athenex, Inc. Business Overview
 Table 83. Athenex, Inc. 503B Compounding Pharmacies Product
 Table 84. Athenex, Inc. Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 85. Athenex, Inc. Recent Development
 Table 86. Avella Specialty Pharmacy Company Details
 Table 87. Avella Specialty Pharmacy Business Overview
 Table 88. Avella Specialty Pharmacy 503B Compounding Pharmacies Product
 Table 89. Avella Specialty Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 90. Avella Specialty Pharmacy Recent Development
 Table 91. Atlas Pharmaceuticals Company Details
 Table 92. Atlas Pharmaceuticals Business Overview
 Table 93. Atlas Pharmaceuticals 503B Compounding Pharmacies Product
 Table 94. Atlas Pharmaceuticals Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 95. Atlas Pharmaceuticals Recent Development
 Table 96. Empower Pharmacy Company Details
 Table 97. Empower Pharmacy Business Overview
 Table 98. Empower Pharmacy 503B Compounding Pharmacies Product
 Table 99. Empower Pharmacy Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 100. Empower Pharmacy Recent Development
 Table 101. Carie Boyd’S Prescription Shop Company Details
 Table 102. Carie Boyd’S Prescription Shop Business Overview
 Table 103. Carie Boyd’S Prescription Shop 503B Compounding Pharmacies Product
 Table 104. Carie Boyd’S Prescription Shop Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 105. Carie Boyd’S Prescription Shop Recent Development
 Table 106. Edge Pharma, Imprimis NJOF Company Details
 Table 107. Edge Pharma, Imprimis NJOF Business Overview
 Table 108. Edge Pharma, Imprimis NJOF 503B Compounding Pharmacies Product
 Table 109. Edge Pharma, Imprimis NJOF Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 110. Edge Pharma, Imprimis NJOF Recent Development
 Table 111. IntegraDose Compounding services Company Details
 Table 112. IntegraDose Compounding services Business Overview
 Table 113. IntegraDose Compounding services 503B Compounding Pharmacies Product
 Table 114. IntegraDose Compounding services Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 115. IntegraDose Compounding services Recent Development
 Table 116. Wells Pharma of Houston, LLC Company Details
 Table 117. Wells Pharma of Houston, LLC Business Overview
 Table 118. Wells Pharma of Houston, LLC 503B Compounding Pharmacies Product
 Table 119. Wells Pharma of Houston, LLC Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 120. Wells Pharma of Houston, LLC Recent Development
 Table 121. US Compounding Inc. Company Details
 Table 122. US Compounding Inc. Business Overview
 Table 123. US Compounding Inc. 503B Compounding Pharmacies Product
 Table 124. US Compounding Inc. Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 125. US Compounding Inc. Recent Development
 Table 126. SCA Pharma Company Details
 Table 127. SCA Pharma Business Overview
 Table 128. SCA Pharma 503B Compounding Pharmacies Product
 Table 129. SCA Pharma Revenue in 503B Compounding Pharmacies Business (2020-2025) & (US$ Million)
 Table 130. SCA Pharma Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. 503B Compounding Pharmacies Picture
 Figure 2. Global 503B Compounding Pharmacies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 503B Compounding Pharmacies Market Share by Type: 2024 VS 2031
 Figure 4. Acetaminophen Features
 Figure 5. Phenylephrine Features
 Figure 6. Midazolam Features
 Figure 7. Esmolol Features
 Figure 8. Vancomycin Features
 Figure 9. Epinephrine Features
 Figure 10. Adenocaine Features
 Figure 11. Fentanyl/ Bupivacaine Features
 Figure 12. Morphine Features
 Figure 13. Global 503B Compounding Pharmacies Market Size by Application (2020-2031) & (US$ Million)
 Figure 14. Global 503B Compounding Pharmacies Market Share by Application: 2024 VS 2031
 Figure 15. On-line Case Studies
 Figure 16. Offline Case Studies
 Figure 17. 503B Compounding Pharmacies Report Years Considered
 Figure 18. Global 503B Compounding Pharmacies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global 503B Compounding Pharmacies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global 503B Compounding Pharmacies Market Share by Region: 2024 VS 2031
 Figure 21. Global 503B Compounding Pharmacies Market Share by Players in 2024
 Figure 22. Global Top 503B Compounding Pharmacies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 503B Compounding Pharmacies as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by 503B Compounding Pharmacies Revenue in 2024
 Figure 24. North America 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America 503B Compounding Pharmacies Market Share by Country (2020-2031)
 Figure 26. United States 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe 503B Compounding Pharmacies Market Share by Country (2020-2031)
 Figure 30. Germany 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific 503B Compounding Pharmacies Market Share by Region (2020-2031)
 Figure 38. China 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America 503B Compounding Pharmacies Market Share by Country (2020-2031)
 Figure 46. Mexico 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa 503B Compounding Pharmacies Market Share by Country (2020-2031)
 Figure 50. Turkey 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE 503B Compounding Pharmacies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Central Admixture Pharmacy Services Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 54. Nephron Pharmaceuticals Corporation Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 55. QuVa Pharma Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 56. Olympia Pharmacy Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 57. ASP Cares Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 58. Fagron Compounding Pharmacies Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 59. Athenex, Inc. Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 60. Avella Specialty Pharmacy Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 61. Atlas Pharmaceuticals Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 62. Empower Pharmacy Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 63. Carie Boyd’S Prescription Shop Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 64. Edge Pharma, Imprimis NJOF Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 65. IntegraDose Compounding services Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 66. Wells Pharma of Houston, LLC Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 67. US Compounding Inc. Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 68. SCA Pharma Revenue Growth Rate in 503B Compounding Pharmacies Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine Compounding Robot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Counters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specialty Pharmacy Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacy Franchise Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugstore Chain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Retail Chain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Store Franchise Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Pharmaceuticals Cosmetics Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacy And Drug Store Franchises Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacy and Drug Store Franchise Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Compounded Sterile Preparations Pharmacy Market Research Report 2025
Drug Reference App Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicinal Cannabis Compounding Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Counters Market Research Report 2025
Medicine Automated Dispensing Cabinets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical 3PL Service Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions